Mark S. Diamond
Immunology · 2005–2011
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 38 citations into it
- Oncology — 14 citations into it
Whom Mark S. Diamond trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Dunn
- R. Steinman
- M. Smyth
- Robert Schreiber
- Daniel B. Stetson
- M. Vesely
- Lloyd J. Old
- Julie M. Curtsinger
- R. Medzhitov
- Jacques Banchereau
Papers from Mark S. Diamond's perspective
Ordered by how strongly the researchers Mark S. Diamond trusts endorse each paper. Same corpus, a different order for every researcher.
- The origin and development of nonlymphoid tissue CD103+ DCs (Journal of Experimental Medicine)
- Plasmacytoid dendritic cells in immunity (Nature Immunology)
- Links between innate and adaptive immunity via type I interferon. (Current Opinion in Immunology)
- Type I interferons in host defense. (Immunity)
- Biology of hematopoietic stem cells and progenitors: implications for clinical application. (Annual Review of Immunology)
- Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 (Journal of Immunology)
- Tolerogenic dendritic cells. (Annual Review of Immunology)
- Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
- Natural innate and adaptive immunity to cancer. (Annual Review of Immunology)
- Taking dendritic cells into medicine (Nature)
Their papers
- Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity (2008) — 2,009 citations
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors (2011) — 1,089 citations
- A critical function for type I interferons in cancer immunoediting (2005) — 618 citations